🔴Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.
HB 46
🔴 HB 46: Medical cannabis expansion with loss of public control
What it says it does:
HB 46 expands Texas’s Compassionate Use Program by adding more qualifying conditions, allowing licensed dispensaries to open satellite sites, and permitting inhalation-based delivery like vaporizers for low-THC cannabis. It is framed as a reform to improve access for patients statewide.
What it actually changes:
The bill shifts major authority to state agencies. It allows the Department of Public Safety and the Department of State Health Services to decide who qualifies for treatment, who gets licensed, and what products are legal. It also removes the right to a hearing if a license application is denied and blocks cities and counties from prohibiting dispensaries in their jurisdictions.
Who is pushing for it:
Supporters listed in the files include Texas Original Compassionate Cultivation, Goodblend Texas, Blissful CannaCo, Village Farms, and the Coalition of Texans with Disabilities. These companies and organizations registered in support and submitted testimony.
Who benefits:
Current license holders benefit from market expansion and new regional opportunities. The state gains millions in licensing fees without public scoring or LBB oversight. Agency officials gain expanded rulemaking authority over products, conditions, and enforcement.
Who gets left out or exposed:
Veterans, small businesses, and rural applicants denied licenses have no appeal process. Local governments lose zoning authority over dispensary locations. Patients and communities lose transparency over how decisions are made and by whom.
Why this matters long term:
HB 46 creates a structural model where executive agencies can quietly control access, eligibility, and market rules without legislative approval or public input. It sets a precedent for future deregulation and centralized discretion across other sectors like health, education, or licensing.
What to watch next:
Watch for DPS and DSHS rulemaking around future conditions, vendor approvals, and licensing terms. Also monitor how quickly licenses are awarded and whether public scoring or audits are ever implemented.
Bottom line:
This bill expands access to medical cannabis but shuts the public out of key decisions. It removes oversight, weakens local control, and concentrates power in two state agencies. The promise of compassion is being used to create a controlled, insider-friendly market.
#HB46 #TexasPolicy #CannabisControl #MedicalAccess #ExecutiveOverreach #StayInformed